Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-88.09	19.17	160.99
Graham Fair Price	204.76	928.83	304.78
PEG	-98.89	< 0.005	-0.60
Price/Book	-1.28	0.88	0.89
Price/Cash Flow	inf	0.00	141.04
Prices/Earnings	-88.06	5.15	43.15
Price/Sales	-8.30	1.09	1.19
Price/FCF	inf	0.00	141.04
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	84.01	0.13	0.07
Operating Margin	750.24	0.07	< 0.005
ROA	742.46	0.02	< 0.005
ROE	< 0.005	0.04	726.68
ROIC	< 0.005	0.02	761.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.11	0.32	-64.96
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.69	8.70	1170.24
EPS QOQ	-0.72	7.76	976.68
FCF QOQ	-0.01	-1.00	-7450.00
Revenue QOQ	-0.02	0.14	678.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	13.94	16.46	18.08
Days Sales Outstanding (DSO)	184.04	172.69	-6.17
Inventory Turnover	6.46	5.47	-15.31
Debt/Capitalization	0.40	0.35	-10.59
Quick Ratio	1.33	1.36	2.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	894.07	947.67	6.00
Cash	307.51	306.22	-0.42
Capex	0.00	0.00	0.00
Free Cash Flow	5.65	0.00	inf
Revenue	668.61	762.97	14.11
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.46	1.50	3.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	41.75	3.96	-90.52
Naive Interpretation	Member

06 - Financial Health · Weak

Rating